英搏爾(300681.SZ):與杭叉集團擬共同成立合資公司 進一步拓展電動工業車輛領域業務
格隆匯7月14日丨英搏爾(300681.SZ)公佈,為進一步拓展電動工業車輛領域業務,公司與杭叉集團於近日簽訂《關於設立浙江華航電氣驅動有限公司合作合同》,擬共同成立合資公司。
合資公司的註冊資本為5,000萬元人民幣,公司以人民幣現金認繳出資額1,750萬元,佔註冊資本的35%;杭叉集團以人民幣現金認繳出資額2,750萬元,佔註冊資本的55%;雙方管理團隊設立的合夥企業杭州杭爾企業管理合夥企業(有限合夥)(稱“杭州杭爾”)以人民幣現金認繳出資額500萬元,佔註冊資本的10%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.